Monitor for a prospectus supplement or 424B filing that would disclose the size and terms of any actual offering. The shelf effectiveness itself is not a trading event, but it sets the stage for potential capital raises that could pressure the stock.
Price Chart
Executive Summary
Clearmind Medicine Inc.'s shelf registration statement (File No. 333-291817) became effective on June 18, 2026, allowing the company to sell securities from time to time. For a micro-cap biotech with a $3M market cap, this introduces potential dilution overhang, though no specific offering has been announced.
Key Facts
- Shelf registration (File No. 333-291817) declared effective on 2026-06-18.
- Company can now offer and sell securities (shares, warrants, etc.) at its discretion.
- No offering size, pricing, or terms disclosed in the EFFECT notice.
- Market cap is approximately $3M; recent insider activity shows $330K in buys and $119K in sells over the past 30 days.
Financial Impact
Potential dilution from future offerings; amount and timing unknown.
Risk Factors
- Dilution risk if the company conducts an offering under the shelf.
- Micro-cap biotech may need to raise capital, increasing likelihood of near-term dilution.
- Lack of transparency on intended use of proceeds adds uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002060 |
| Document: 9999999995-26-002060-index.html | 9999999995-26-002060 |
| Document: 9999999995-26-002060.txt | 9999999995-26-002060 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $6.12 (−2.02%) |
Oct 13, 2026 14d ago | 6-K | $6.23 | awaiting T+60 | — | $6.12 (−1.75%) |
Oct 8, 2026 18d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.26%) |
Oct 7, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $6.12 (−7.26%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $6.12 (+620.12%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $6.12 (+620.12%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $6.12 (−10.82%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $6.12 (+548.41%) |
Sep 8, 2026 6w ago | 6-K | $1.03 | awaiting T+60 | — | $6.12 (+494.27%) |
Sep 4, 2026 7w ago | 6-K | $1.16 | awaiting T+60 | — | $6.12 (−427.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers